Franklin M. Robinson

Statistics

Publications

Citations

895

H-Index

Active since

1955

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Franklin M. Robinson is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and structure-activity relationships.

Publications per year

1955–1988

Publications

A new class of angiotensin-converting enzyme inhibitors

Arthur A. Patchett, Elbert E. Harris, Edward W. Tristram et al. · Nature · 1980 · 706 citations

Medicine, Medicinal Chemistry, Pharmacology +8

RELATIONSHIP BETWEEN STRUCTURE OF BENZIMIDAZOLE DERIVATIVES AND SELECTIVE VIRUS INHIBITORY ACTIVITY

Igor Tamm, Rostom Bablanian, M. M. Nemes et al. · The Journal of Experimental Medicine · 1961 · 70 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

COENZYME Q. II. SYNTHESIS OF 6-FARNESYL- AND 6-PHYTYL-DERIVATIVES OF 2,3-DIMETHOXY-5-METHYLBENZOQUINONE AND RELATED ANALOGS

Clifford H. Shunk, Bruce O. Linn, Emily L. Wong et al. · Journal of the American Chemical Society · 1958 · 66 citations

Pharmacy, Chemistry, Medicinal Chemistry +11

VITAMIN B<sub>12</sub>. XXVI. DEGRADATION OF FACTOR III TO 5-HYDROXYBENZIMIDAZOLE AND DERIVATIVES AND BIOSYNTHESIS OF FACTOR III

Franklin M. Robinson, Ian M. Miller, James F. McPherson et al. · Journal of the American Chemical Society · 1955 · 16 citations

Life Sciences, Biochemistry, Nutrition +11

Use of the thallium trinitrate catalyzed rearrangement of ketones in the synthesis of an acidic morphinan derivative

Patrice C. Bélanger, C. S. ROONEY, Franklin M. Robinson et al. · The Journal of Organic Chemistry · 1978 · 14 citations

Natural Sciences, Biochemistry, Chemistry +6

1–5 of 7